Late gadolinium-enhanced cardiac magnetic resonance

Current Cardiology Reports

Volumn 10, Issue 1, 2008, Pages 72-78

  Lin, David ^a   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; RADIOISOTOPE;

ACUTE HEART INFARCTION; CARDIAC MAGNETIC RESONANCE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; IMAGE PROCESSING; LATE GADOLINIUM ENHANCEMENT; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SENSITIVITY AND SPECIFICITY; STRESS RADIOGRAPHY; CARDIOVASCULAR DISEASE; HEART MUSCLE; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

CARDIOMYOPATHY, DILATED; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIUM; PROGNOSIS; RADIOISOTOPES; TIME FACTORS;

EID: 44449160946     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-008-0014-4     Document Type: Review

References (53)

1. Risk stratification and survival after myocardial infarction [no authors listed]. N Engl J Med 1983, 309: 331-336.
2. Steen H, Giannitsis E, Futterer S, et al.: Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 2006, 48: 2192-2194.
3. Wagner A, Mahrholdt H, Holly TA, et al.: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 2003, 361: 374-379.
4. Assomull RG, Prasad SK, Lyne J, et al.: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48: 1977-1985.
5. Moon JC, McKenna WJ, McCrohon JA, et al.: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41: 1561-1567.
6. Kwong RY, Chan AK, Brown KA, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113: 2733-2743.
7. Allman KC, Shaw LJ, Hachamovitch R, et al.: Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002, 39: 1151-1158.
8. Hombach V, Grebe O, Merkle N, et al.: Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005, 26: 549-557.
9. Wu KC, Zerhouni EA, Judd RM, et al.: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97: 765-772.
10. Bleeker GB, Kaandorp TA, Lamb HJ, et al.: Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006, 113: 969-976.
11. White JA, Yee R, Yuan X, et al.: Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006, 48: 1953-1960.
12. Simonetti OP, Kim RJ, Fieno DS, et al.: An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001, 218: 215-223.
13. Kellman P, Arai AE, McVeigh ER, et al.: Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002, 47: 372-383.
14. Selvanayagam JB, Porto I, Channon K, et al.: Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005, 111: 1027-1032.
15. Sievers B, Elliott MD, Hurwitz LM, et al.: Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation 2007, 115: 236-244.
16. Gersh BJ, Anderson JL: Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm-paradoxic or predictable? Circulation 1993, 88: 296-306.
17. Ragosta M, Camarano G, Kaul S, et al.: Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 1994, 89: 2562-2569.
18. Rogers WJ Jr, Kramer CM, Geskin G, et al.: Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999, 99: 744-750.
19. Choi CJ, Haji-Momenian S, DiMaria JM, et al.: Infarct involution and improved function during healing of acute myocardial infarction: The role of microvascular obstruction. J Cardiovasc Magn Reson 2004, 6: 917-925.
20. Ibrahim T, Bulow HP, Hackl T, et al.: Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 2007, 49: 208-216.
21. Sheifer SE, Manolio TA, Gersh BJ: Unrecognized myocardial infarction. Ann Intern Med 2001, 135: 801-811.
22. Barbier CE, Bjerner T, Johansson L, et al.: Myocardial scars more frequent than expected: Magnetic resonance imaging detects potential risk group. J Am Coll Cardiol 2006, 48: 765-771.
23. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343: 1445-1453.
24. Selvanayagam JB, Kardos A, Francis JM, et al.: Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004, 110: 1535-1541.
25. Wellnhofer E, Bocksch W, Hiemann N, et al.: Shear stress and vascular remodeling: Study of cardiac allograft coronary artery disease as a model of diffuse atherosclerosis. J Heart Lung Transplant 2002, 21: 405-416.
26. Bove CM, DiMaria JM, Voros S, et al.: Dobutamine response and myocardial infarct transmurality: Functional improvement after coronary artery bypass grafting-initial experience. Radiology 2006, 240: 835-841.
27. Gutberlet M, Frohlich M, Mehl S, et al.: Myocardial viability assessment in patients with highly impaired left ventricular function: Comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization. Eur Radiol 2005, 15: 872-880.
28. Klem I, Heitner JF, Shah DJ, et al.: Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006, 47: 1630-1638.
29. Ingkanisorn WP, Kwong RY, Bohme NS, et al.: Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006, 47: 1427-1432.
30. McCrohon JA, Moon JC, Prasad SK, et al.: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108: 54-59.
31. Soriano CJ, Ridocci F, Estornell J, et al.: Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 2005, 45: 743-748.
32. Schietinger BJ, Voros S, Isbell DC, et al.: Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure? Int J Cardiovasc Imaging 2007, 23: 595-602.
33. Felker GM, Hu W, Hare JM, et al.: The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 1999, 78: 270-283.
34. Doolan A, Langlois N, Semsarian C: Causes of sudden cardiac death in young Australians. Med J Aust 2004, 180: 110-112.
35. Fuster V, Gersh BJ, Giuliani ER, et al.: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981, 47: 525-531.
36. Kawai C: From myocarditis to cMrdiomyopathy: mechanisms of inflammation and cell death: Learning from the past for the future. Circulation 1999, 99: 1091-1100.
37. Mahrholdt H, Goedecke C, Wagner A, et al.: Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation 2004, 109: 1250-1258.
38. Mahrholdt H, Wagner A, Deluigi CC, et al.: Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006, 114: 1581-1590.
39. Wagner A, Schulz-Menger J, Dietz R, et al.: Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging. MAGMA 2003, 16: 17-20.
40. Rickers C, Wilke NM, Jerosch-Herold M, et al.: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112: 855-861.
41. Moon JC, Reed E, Sheppard MN, et al.: The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 43: 2260-2264.
42. Harris KM, Spirito P, Maron MS, et al.: Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006, 114: 216-225.
43. Smedema JP, Snoep G, van Kroonenburgh MP, et al.: Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005, 45: 1683-1690.
44. Stauder NI, Bader B, Fenchel M, et al.: Images in cardiovascular medicine. Follow-up of cardiac sarcoidosis by magnetic resonance imaging. Circulation 2005, 111: E158-e160.
45. Maceira AM, Joshi J, Prasad SK, et al.: Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005, 111: 186-193.
46. Tandri H, Saranathan M, Rodriguez ER, et al.: Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45: 98-103.
47. Sen-Chowdhry S, Syrris P, Ward D, et al.: Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007, 115: 1710-1720.
48. Babu-Narayan SV, Kilner PJ, Li W, et al.: Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 2006, 113: 405-413.
49. Blyth KG, Groenning BA, Martin TN, et al.: Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005, 26: 1993-1999.
50. Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346: 1845-1853.
51. Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350: 2140-2150.
52. Cazeau S, Leclercq C, Lavergne T, et al.: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 344: 873-880.
53. Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352: 1539-1549.